Mergers & Acquisitions

The independent public listing of Tübingen-based mRNA pioneer CureVac has been formally terminated. The company's shares have been delisted from...

Shares of Energy Fuels experienced heightened volatility as the market digested the company's move to significantly expand its footprint in...

Following a catastrophic decline that erased more than 80% of its value in just one month, shares of Diginex on...

Shares of AnaptysBio are trading marginally lower than the previous session's close. The company's valuation is currently tethered to a...

A prominent Wall Street firm has ignited significant interest in Fannie Mae (ISIN: US3135861090), projecting a dramatic revaluation for the...

Despite an aggressive international growth strategy, Tilray Brands' share price continues to struggle. The company's operational advances, including a new...

The streaming giant Netflix has delivered a powerful finish to 2025, reporting fourth-quarter results that handily surpassed market projections. While...

Nvidia is not content to simply maintain its commanding lead in artificial intelligence. The chipmaker has made a decisive $2...

A period of aggressive acquisitions and strategic refocusing defined 2025 for Healwell AI, dramatically reshaping its financial profile. However, the...

Market analysts continue to closely monitor UBS as it navigates a complex post-acquisition landscape. The investment firm Jefferies has reiterated...